Kontafarma China Holdings Ltd (HK:1312) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Kontafarma China Holdings Ltd has announced changes to its board of directors effective 7 June 2024, revealing a new composition of executive and non-executive members, including Wang Feifei as Chairman and President. The company has also detailed the structure of its seven board committees, specifying the roles of each director across these committees, with clear designations for chairpersons and members.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.